Induct AS (OSL:INDCT)
4.320
-0.060 (-1.37%)
At close: Dec 3, 2025
Induct AS Revenue
Induct AS had revenue of 2.61M NOK in the quarter ending September 30, 2025, a decrease of -37.81%. This brings the company's revenue in the last twelve months to 15.75M, down -15.01% year-over-year. In the year 2024, Induct AS had annual revenue of 17.96M, down -14.62%.
Revenue (ttm)
15.75M
Revenue Growth
-15.01%
P/S Ratio
8.71
Revenue / Employee
1.21M
Employees
13
Market Cap
137.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.96M | -3.08M | -14.62% |
| Dec 31, 2023 | 21.04M | 1.60M | 8.25% |
| Dec 31, 2022 | 19.44M | 5.13M | 35.85% |
| Dec 31, 2021 | 14.31M | 2.70M | 23.32% |
| Dec 31, 2020 | 11.60M | -2.18M | -15.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 662.18M |
| Nordhealth AS | 590.33M |
| Navamedic ASA | 539.42M |
| Photocure ASA | 537.59M |
| Omda AS | 476.29M |
| Vistin Pharma ASA | 455.25M |
| Gentian Diagnostics ASA | 172.52M |
| ArcticZymes Technologies ASA | 109.99M |